Kit Check co-founder and CEO, Kevin MacDonald, explores the ways AI and RFID enabled tools can help hospitals navigate the most pressing challenges of the COVID-19 pandemic, include drug shortages.
Has your team outgrown your current tools and software in the hospital pharmacy? It’s time to upgrade to a solution that evolves with you, and one that helps facilitate cross-departmental communication and workflow efficiency. The answer is Bluesight: a solution that brings simplicity, visibility, and predictability to your controlled substance management. The best thing about our end-to-end solution is that … Read More
Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of September 30, 2020. Data was pulled from health systems across the United States.
Beju’s career thus far has provided him a unique set of skills – he’s equipped with deep knowledge of all aspects of pharmacy medication use processes, from frontline patient-centered care to data-driven analytics and system-based thinking, and he’s able to blend this knowledge to offer pragmatic solutions in response to issues within the industry.
DoseID members, Kit Check and Sandoz, have agreed to launch RFID-tagged injectable medicines Two NDCs of Sandoz RFID-tagged medicines will be available in October 2020, with several more available through Q1 2021 The RFID-tagged medicines are registered into the cloud-based Registry at the site of production and can be scanned in downstream Kit Check scanning stations in hospitals to ensure … Read More
SCA Pharma’s extensive product catalog will be combined with Kit Check’s advancements in RFID tagging technology to present dynamic products to SCA customers.
Kit Check Extends Partnership with Premier Inc. in Multi-Year Contract to Further Advance Pharmacy Visibility with Diversion Detection Software and Medication Management
Attorney Mialeeka Williams-Bibbs joins Kit Check team amid company’s push to continue to revolutionize the medication supply chain.
Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of June 30, 2020. Data was pulled from health systems across the United States.